Form 4: Precigen CEO Helen Sabzevari Reports Stock Transactions
SEC Form 4 Filing
Helen Sabzevari, President and CEO of Precigen, Inc., reports the acquisition and disposal of common stock and restricted stock units on April 5, 2024.
Summary
- On April 5, 2024, Helen Sabzevari, the President and CEO of Precigen, Inc., engaged in transactions involving the company's stock.
- She acquired 1,071,429 shares of common stock through the vesting of restricted stock units (RSUs).
- Simultaneously, she disposed of 410,357 shares to cover income tax withholding obligations related to the RSU settlement at a price of $1.4 per share.
- Following these transactions, Sabzevari directly owns 2,221,076 shares of Precigen common stock.
- She also continues to hold 0 restricted stock units.
Sentiment
Score: 5
Explanation: The document is a standard regulatory filing detailing stock transactions, with no inherent positive or negative sentiment. It reflects routine compensation-related activities.
Industry Context
Form 4 filings are a routine part of insider trading regulations, providing transparency into the transactions of company executives and directors.
Stakeholder Impact
- The transactions may have a minor impact on shareholders due to the change in ownership, but the overall effect is likely minimal as it relates to standard executive compensation.
Key Dates
| Date | Description |
|---|---|
| 04/05/2024 | Date of stock transactions (acquisition and disposal of shares and RSUs). |
| 04/09/2024 | Date of signature for the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.